Search Results - "Baker, Nevin C"

Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee Meeting About Vorapaxar by Baker, Nevin C, Lipinski, Michael J, Lhermusier, Thibault, Waksman, Ron

Get full text

A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction by Lipinski, Michael J., MD, PhD, Escárcega, Ricardo O., MD, D'Ascenzo, Fabrizio, MD, Magalhães, Marco A., MD, Baker, Nevin C., DO, Torguson, Rebecca, MPH, Chen, Fang, PhD, Epstein, Stephen E., MD, Miró, Òscar, MD, PhD, Llorens, Pere, MD, PhD, Giannitsis, Evangelos, MD, Lotze, Ulrich, MD, Lefebvre, Sophie, PhD, Sebbane, Mustapha, MD, PhD, Cristol, Jean-Paul, MD, PhD, Chenevier-Gobeaux, Camille, PharmD, PhD, Meune, Christophe, MD, PhD, Eggers, Kai M., MD, PhD, Charpentier, Sandrine, MD, PhD, Twerenbold, Raphael, MD, Mueller, Christian, MD, Biondi-Zoccai, Giuseppe, MD, Waksman, Ron, MD

“…Multiple studies have evaluated copeptin, a surrogate for arginine vasopressin, in the diagnosis of acute myocardial infarction (AMI) with mixed results. A…”
Get full text

Impact of Pre-Procedural Serum Albumin Levels on Outcome of Patients Undergoing Transcatheter Aortic Valve Replacement by Koifman, Edward, MD, Magalhaes, Marco A., MD, Ben-Dor, Itsik, MD, Kiramijyan, Sarkis, MD, Escarcega, Ricardo O., MD, Fang, Chen, PhD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Negi, Smita I., MD, Baker, Nevin C., DO, Minha, Sa'ar, MD, Corso, Paul J., MD, Shults, Christian, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Risk assessment for transcatheter aortic valve replacement (TAVR) patients is challenging, and surgical scores do not optimally correlate with outcome. The aim…”
Get full text

Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee Meeting Regarding Cangrelor by Lhermusier, Thibault, MD, PhD, Baker, Nevin C., DO, Waksman, Ron, MD

“…Landmark clinical trials have established the benefit of P2Y12 inhibitors in the setting of acute coronary syndrome and percutaneous coronary intervention. On…”
Get full text

Impact of Blood Transfusions on Short- and Long-Term Mortality in Patients Who Underwent Transcatheter Aortic Valve Implantation by Escárcega, Ricardo O., MD, Lipinski, Michael J., MD, PhD, Magalhaes, Marco A., MD, Baker, Nevin C., DO, Minha, Sa'ar, MD, Okubagzi, Petros G., MD, Torguson, Rebecca, MPH, Chen, Fang, PhD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Baseline anemia is associated with transfusions and increased risk of mortality in patients who underwent cardiac surgery and percutaneous coronary…”
Get full text

Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement by Escárcega, Ricardo O., MD, Baker, Nevin C., DO, Lipinski, Michael J., MD, PhD, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Magalhaes, Marco A., MD, Gai, Jiaxiang, MSPH, Torguson, Rebecca, MPH, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Transcatheter aortic valve replacement (TAVR) is the current standard for nonoperable and high-risk surgical patients with aortic stenosis,…”
Get full text

Analysis of Long-Term Survival Following Transcatheter Aortic Valve Implantation from a Single High-Volume Center by Escárcega, Ricardo O., MD, Lipinski, Michael J., MD, PhD, Baker, Nevin C., DO, Magalhaes, Marco A., MD, Minha, Sa'ar, MD, Torguson, Rebecca, MPH, Chen, Fang, PhD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Corso, Paul, MD, Waksman, Ron, MD

“…Mortality after transcatheter aortic valve implantation (TAVI) has been reported to range up to 3 years. However, long-term mortality remains underexplored…”
Get full text

Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin by Baker, Nevin C., DO, O'Connell, Erik W., DO, Htun, Wah Wah, MD, Sun, Haiyan, MS, Green, Sandy M., MD, Skelding, Kimberly A., MD, Blankenship, James C., MD, Scott, Thomas D., DO, Berger, Peter B., MD

“…Objective To evaluate access site and other bleeding complications associated with radial versus femoral access in patients receiving oral anticoagulation…”
Get full text

Outcome of Left-Sided Cardiac Remodeling in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation by Magalhaes, Marco A., MD, Koifman, Edward, MD, Torguson, Rebecca, MPH, Minha, Sa'ar, MD, Gai, Jiaxiang, MSPH, Kiramijyan, Sarkis, MD, Escarcega, Ricardo O., MD, Baker, Nevin C., DO, Wang, Zuyue, MD, Goldstein, Steven, MD, Asch, Federico, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Left-sided cardiac remodeling in patients with severe aortic stenosis (AS) was associated with improved outcome; however, there are scarce data on remodeling…”
Get full text

The choice of arterial access for percutaneous coronary intervention and its impact on outcome: An expert opinion perspective by Baker, Nevin C., DO, Ansel, Gary M., MD, Rao, Sunil V., MD, Jolly, Sanjit S., MD, Pichard, Augusto D., MD, Steinberg, Daniel, MD, Lipinski, Michael J., MD, PhD, Escarcega, Ricardo O., MD, Minha, Sa'ar, MD, Lhermusier, Thibault, MD, PhD, Magalhães, Marco A., MD, Waksman, Ron, MD

“…The prevention of major bleeding during percutaneous coronary intervention is one of the most widely discussed and often controversial topics within…”
Get full text

Impact of Baseline Mitral Regurgitation on Short- and Long-Term Outcomes Following Transcatheter Aortic Valve Replacement by Kiramijyan, Sarkis, MD, Magalhaes, Marco A., MD, Koifman, Edward, MD, Didier, Romain, MD, Escarcega, Ricardo O., MD, Minha, Sa’ar, MD, Baker, Nevin C., DO, Negi, Smita I., MD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Okubagzi, Petros, MD, Asch, Federico M., MD, Gaglia, Michael A., MD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract Background The prevalence of concomitant significant mitral regurgitation (MR) in patients with severe aortic stenosis undergoing transcatheter aortic…”
Get full text

Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement by Kiramijyan, Sarkis, MD, Koifman, Edward, MD, Asch, Federico M., MD, Magalhaes, Marco A., MD, Didier, Romain, MD, Escarcega, Ricardo O., MD, Negi, Smita I., MD, Baker, Nevin C., DO, Jerusalem, Zachary D., MD, Gai, Jiaxiang, MSPH, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Wang, Zuyue, MD, Shults, Christian C., MD, Ben-Dor, Itsik, MD, Corso, Paul J., MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The impact of the specific etiology of mitral regurgitation (MR) on outcomes in the transcatheter aortic valve replacement (TAVR) population is unknown. This…”
Get full text

Definitions of Periprocedural Myocardial Infarction as Surrogates for Catheterization Laboratory Quality or Clinical Trial End Points by Baker, Nevin C., DO, Lipinski, Michael J., MD, PhD, Escarcega, Ricardo O., MD, Magalhaes, Marco A., MD, Minha, Sa'ar, MD, Torguson, Rebecca, MPH, Waksman, Ron, MD

“…A consensus on what constitutes a clinically meaningful periprocedural myocardial infarction (PMI) remains highly debated. We evaluated the accuracy of 2 PMI…”
Get full text

Safety Net Hospitals and Cardiovascular Outcomes: Consider the Source? by Baker, Nevin C.

Get full text

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis by Lipinski, Michael J, Benedetto, Umberto, Escarcega, Ricardo O, Biondi-Zoccai, Giuseppe, Lhermusier, Thibault, Baker, Nevin C, Torguson, Rebecca, Brewer, Jr, H Bryan, Waksman, Ron

“…We performed a network meta-analysis of randomized controlled trials (RCTs) in patients with primary hypercholesterolaemia to compare the impact of proprotein…”
Get full text

Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement with the Self-Expanding CoreValve versus the Balloon-Expandable SAPIEN XT Valve by Kiramijyan, Sarkis, MD, Magalhaes, Marco A., MD, Koifman, Edward, MD, Didier, Romain, MD, Escarcega, Ricardo O., MD, Baker, Nevin C., DO, Negi, Smita I., MD, Minha, Sa’ar, MD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Asch, Federico M., MD, Wang, Zuyue, MD, Okubagzi, Petros, MD, Gaglia, Michael A., MD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract The incidence of aortic regurgitation (AR) post transcatheter aortic valve replacement (TAVR) among a self-expanding and a balloon-expandable system…”
Get full text

Clinical Significance of Cardiomegaly Caused by Cardiac Adiposity by Baker, Nevin C., DO, Assal, Chafik, MD, Shirani, Jamshid, MD

“…Enlarged cardiac silhouette on chest x-ray (CXR) in the absence of cardiopulmonary disease is often dismissed as “pseudocardiomegaly.” We aimed to assess the…”
Get full text

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis by Lipinski, Michael J, Escarcega, Ricardo O, Baker, Nevin C, Benn, Hadiya A, Gaglia, Jr, Michael A, Torguson, Rebecca, Waksman, Ron

“…The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement of an ABSORB…”
Get full text

A Time-Out for Arterial Access by Baker, Nevin C., Lee, David

Get full text

Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial by Yerasi, Charan, Baker, Nevin C, Jonnalagadda, Anil K, Torguson, Rebecca, Singh, Suman, Vies, Judith, Waksman, Ron

“…The screening of patients referred for the Symplicity Renal-Denervation Catheter Therapy on Resistant Hypertension (SYMPLICITY HTN-3) trial was rigorous, with…”
Get more information